Pharmacy Podcast Network

Podcast Participants: Mike Baldzicki (AscellaHealth), Randy Falkenrath (President, Onco360), Justin Manning, PharmD (Group Vice President, Business Development, Vivid Clear Rx)

Summary: The specialty pharmacy patient journey is a process, and it starts at the point of care with patient and prescriber, and it goes all the way through the treatment of therapy. Specialty Pharmacy is defined as the service created to manage the handling and service requirements of specialty pharmaceuticals, including dispensing, distribution, reimbursement, case-management and other services specific to patients with rare and/or chronic diseases. There are a lot of extra steps in dispensing a specialty medication, so there's a lot of work to be done by pharmacists and care coordination teams before the specialty drug is given to the patient. Obviously, there’s a higher cost, and so it takes more personnel and systems, so there is more patient coordination needed prior to the pharmacy to dispense that specialty medication. The value of the specialty pharmacist in helping patients to access treatment, adhere to treatment, and really get the best possible outcome of treatment really cannot be overstressed as specialty pharmacist are often responsible for selecting the most appropriate therapy based on the patient's clinical and financial profile or reviewing that prescribed medication to ensure access for the patient. The Specialty Pharmacy Care Teams provide significant mentoring to patients to ensure not only safety but also effectiveness and being proactive and changing therapy so that patients are really getting the best possible benefit or changing to a different medication that may give them a better effect. The specialty pharmacists are an anchor during therapy that they can rely on to make sure that they are helping them deal with complex, challenging, and sometimes lifelong therapies as the specialty care teams play an important role in the patient care journey.

Learn more about your ad choices. Visit megaphone.fm/adchoices

·      Recognize the role of biomarker expression in the selection of most appropriate treatment options for patients with endometrial cancer

·      Review strategies for identification and management of drug-related toxicities in patients receiving therapy with immune checkpoint inhibitors, targeted agents, or combination therapy

Faculty:

Sarah Hayward, PharmD, BCOP

Clinical Pharmacy Specialist, Gynecologic Oncology

Stephenson Cancer Center at OU Health

University of Oklahoma Health Science Center

Oklahoma City, Oklahoma

Sarah Hayward, PharmD, BCOP, has the following relevant financial relationships with commercial interests to disclose:

Consultant (advisory board): GSK, Seagen/Genmab

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hour (0.05 CEU) under the ACPE universal activity number 0290-0000-22-322-H01-P. The activity is available for CE credit through June 30, 2023.

This educational activity is supported by an educational grant from GlaxoSmithKline

Learn more about your ad choices. Visit megaphone.fm/adchoices

The use of oral therapies for chronic lymphocytic leukemia has had a great impact on patient outcomes and quality of life. Pharmacists can play a key role in assisting with therapy selection, education for patients and the healthcare team, and also managing adverse effects for patients receiving these therapies.

Objectives

Differentiate novel therapies for the treatment of chronic lymphocytic leukemia (CLL) by pharmacologic properties and special considerations for use

Associate drug therapy and safety and efficacy information with treatment selection for patients with CLL

Dr. Katherine Tobon is a clinical pharmacy specialist in malignant hematology with Moffitt Cancer Center in Tampa, Florida.

Dr. Tobon has no relevant financial relationships with commercial interests to disclose.

Accreditation and support statement: 

PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours of knowledge-based credit.

This activity is supported by an educational grant from Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., Administered by Janssen Scientific Affairs, LLC and BeiGene, Ltd.

Learn more about your ad choices. Visit megaphone.fm/adchoices

This podcast will specifically focus on clinical safety and efficacy data supporting the use of new and emerging JAK inhibitors in the management of AD. Practical counseling points for pharmacists to provide individualized care and proper selection of therapy to patients with AD who are initiating therapy with JAK inhibitors will also be discussed. Faculty experts will review audience questions and identify best practices in the management of AD.

o  The Role of JAK Inhibitors in the Management of Atopic Dermatitis: Latest Advances and Best Practices for the Pharmacist

o  Introduction of faculty, affiliations, and disclosures

We would like to thank Sarah Lant, PharmD for her contribution in developing the content for this podcast.

Lana Gerzenshtein, PharmD and Sarah Lant have no relevant financial relationships with commercial interests to disclose.

o  Accreditation and support statement

PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours of knowledge-based credit.

This activity is supported by educational grants from Incyte.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Introduction of faculty and disclosures: 

Dr. Katherine Tobon is a clinical pharmacy specialist in malignant hematology with Moffitt Cancer Center in Tampa, Florida.

Dr. Tobon has no relevant financial relationships with commercial interests to disclose.

Accreditation and support statement: 

PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours of knowledge-based credit.

This activity is supported by an educational grant from Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., Administered by Janssen Scientific Affairs, LLC and BeiGene, Ltd.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Join us today as we talk all things continuous glucose monitoring with a diabetes care and education specialist, Dr. Diana Isaacs. Learn more about the barriers and challenges associated with using CGM for your patients and strategies to overcome these challenges. In addition, Dr. Diana Isaacs walks us through the newest technologies and innovations in the diabetes management space as diabetes care has transformed drastically in the last decade.  

Learn more about your ad choices. Visit megaphone.fm/adchoices

Today I want to highlight the work of another pharmacy and entrepreneur colleague, Dr. Stephanie Young Moss (aka “Yomo”). She caught my eye on Instagram, where she shines her light on wellness, family dynamics, pharmacy practice, and disparities in healthcare. A practical tip that she shared in the episode has stuck with me, about how learning goes both ways. For example, shadowing allows healthcare students to learn from professionals, but the mentors also get the opportunity to learn. A relationship with someone different than you helps you understand where they’re coming from and how you can serve different populations.

Dr. Stephanie received her Doctor of Pharmacy degree from Xavier University of Louisiana College of Pharmacy and a Masters of Health Services Administration with a concentration in Health Economics from The University of Wyoming. She has worked in various areas in pharmacy, Community, Regulatory Compliance, Managed Care, and Health Economics and Outcomes Research.

Over the past 20 years Dr. Moss has advocated for decreasing disparities in health care through her volunteer work. She uses her platform to educate families across the U.S. on ways to decrease and eliminate health disparities by incorporating simple wellness and mental health techniques. Dr. Moss has shared her views on international and national podcasts and local television news stations.

Dr. Stephanie is the creator of the website www.drstephanieyomo.com where you will find practical health and wellness tips, ways to reduce healthcare disparities and simple tips for health and wellness professionals to enhance their presence on social media so they can stand out in their niche, build a successful brand and advocate for important causes.

She is also the owner of Integrative Pharmacy Outcomes and Consulting, which focuses on educating underserved communities on ways to reduce and prevent health disparities.

For nearly 2 decades, Dr. Stephanie has served on various boards and volunteer organizations that focus on health equity, decreasing implicit bias, addressing social determinants of health and empowering communities to advocate for their health. She has served on the boards for The Minority Health Coalition of Marion County and Eskenazi Health Center where she has served as the Clinical Quality Committee Chair, Board Secretary and is currently the Board Treasurer. She resides in Indianapolis, Indiana.

You can connect with Dr. Yomo on all social media (@Dr. Stephanie Yomo) and www.drstephanieyomo.com.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Please join the discussion with David George from Total Dose Pharmacy and First Financial Loan Officer, Drew Hegi from First Financial Bank. 

David George is one of the founders of Total Dose Pharmacy that was established in 2013. He began the startup in Oklahoma and subsequently a second store, Hutton Pharmacy. 

Total Dose aims to be embedded as a healthcare cornerstone of every community in which they are located. They strive to be innovative in the services and products they offer, as well as experts in provision of care and education to patients. Ultimately, their goal is to be the pharmacy franchise where patients want to receive healthcare and people want to work.

Drew Hegi, has been a Loan Officer at FFB since 2012. Drew is also an Independent Pharmacy owner. Drew enjoys coaching buyers through the details of pharmacy ownership. Clear communication helps alleviate concerns, and he understands the necessary skills and tools needed to navigate the process.

Learn more about your ad choices. Visit megaphone.fm/adchoices

https://www.rx-summit.com/

Dr. Mark Garofoli was live and in person at the 2022 RxSummit Conference which hosted anyone and everyone affiliated with and touched by our country's Drug Crisis. The "Pain Guy" spoke with many federal and state leaders (including our U.S. Drug Czar Dr. Gupta, our NIDA Director Dr. Volkow, DEA leadership, and so on), along with fellow conference presenters and attendees alike. Many of those conversations were recorded and contained within this dynamic conference summary episode of the Pain Pod!

Learn more about your ad choices. Visit megaphone.fm/adchoices

Senator Chuck Grassley (R-Iowa) and Maria Cantwell (D-Wash.) introduced the Pharmacy Benefit Manager Transparency Act of 2022 on May 24, which would make it illegal for PBMs to engage in “spread pricing.” Spread pricing occurs when PBMs charge health plans and payers more for a prescription drug than what they reimburse to the pharmacy — and then keep the difference. For example, when a pharmacist fills a prescription, a PBM handles the process, informing the pharmacy it will be reimbursed $90. 

The PBM then charges the health insurance plan $100 for processing the same prescription. The spread of $10 is pocketed by the PBMs. Related: New PBM players banking on drug pricing transparency for success The bipartisan legislation would empower the Federal Trade Commission (FTC) to increase drug pricing transparency and hold pharmacy benefit managers (PBMs) accountable for unfair and deceptive practices that drive up the costs of prescription drugs at the expense of consumers. 

It also would prohibit arbitrary clawbacks of payments made to pharmacies and require PBMs to report to the FTC how much money they make through spread pricing and pharmacy fees.

SCPC, CEO, Alan Rosenbloom & Senior Director, Regulatory Policy at APhA, Michael Baxter join Todd Eury with the Pharmacy Podcast Network to discuss the impact of the Pharmacy Benefit Manager Transparency Act of 2022 on the Pharmacy Profession.

Learn more about your ad choices. Visit megaphone.fm/adchoices